Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 142082, 11 pages
http://dx.doi.org/10.1155/2008/142082
Review Article

PPAR Signaling in Placental Development and Function

1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA
2Departments of Obstetrics and Gynecology and Cell Biology and Physiology, Washington University School of Medicine, P. O. Box 8064, 4566 Scott Avenue, St. Louis, MO 63110, USA

Received 4 June 2007; Accepted 28 August 2007

Academic Editor: P. Froment

Copyright © 2008 Yaacov Barak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ornoy, J. Salamon-Arnon, Z. Ben-Zur, and G. Kohn, “Placental findings in spontaneous abortions and stillbirths,” Teratology, vol. 24, no. 3, pp. 243–252, 1981. View at Publisher · View at Google Scholar
  2. C. Krebs, L. M. Macara, R. Leiser, A. W. Bowman, I. A. Greer, and J. C. P. Kingdom, “Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree,” American Journal of Obstetrics and Gynecology, vol. 175, no. 6, pp. 1534–1542, 1996. View at Publisher · View at Google Scholar
  3. Y. Zhou, C. H. Damsky, K. Chiu, J. M. Roberts, and S. J. Fisher, “Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts,” Journal of Clinical Investigation, vol. 91, no. 3, pp. 950–960, 1993. View at Publisher · View at Google Scholar
  4. J. C. Cross, “How to make a placenta: mechanisms of trophoblast cell differentiation in mice—a review,” Placenta, vol. 26, 1, pp. S3–S9, 2005. View at Publisher · View at Google Scholar
  5. D. G. Simmons and J. C. Cross, “Determinants of trophoblast lineage and cell subtype specification in the mouse placenta,” Developmental Biology, vol. 284, no. 1, pp. 12–24, 2005. View at Publisher · View at Google Scholar
  6. F. Guillemot, A. Nagy, A. Auerbach, J. Rossant, and A. L. Joyner, “Essential role of Mash-2 in extraembryonic development,” Nature, vol. 371, no. 6495, pp. 333–336, 1994. View at Publisher · View at Google Scholar
  7. J. Luo, R. Sladek, J.-A. Bader, A. Matthyssen, J. Rossant, and V. Giguère, “Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-β,” Nature, vol. 388, no. 6644, pp. 778–782, 1997. View at Publisher · View at Google Scholar
  8. H. Yamamoto, M. L. Flannery, S. Kupriyanov et al., “Defective trophoblast function in mice with a targeted mutation of Ets2,” Genes and Development, vol. 12, no. 9, pp. 1315–1326, 1998. View at Publisher · View at Google Scholar
  9. M. Schorpp-Kistner, Z.-Q. Wang, P. Angel, and E. F. Wagner, “JunB is essential for mammalian placentation,” EMBO Journal, vol. 18, no. 4, pp. 934–948, 1999. View at Publisher · View at Google Scholar
  10. M. Schreiber, Z.-Q. Wang, W. Jochum, I. Fetka, C. Elliott, and E. F. Wagner, “Placental vascularisation requires the AP-1 component Fra1,” Development, vol. 127, no. 22, pp. 4937–4948, 2000. View at Google Scholar
  11. R. H. Adams, A. Porras, G. Alonso et al., “Essential role of p38a MAP kinase in placental but not embryonic cardiovascular development,” Molecular Cell, vol. 6, no. 1, pp. 109–116, 2000. View at Publisher · View at Google Scholar
  12. Y. Barak, M. C. Nelson, E. S. Ong et al., “PPAR? is required for placental, cardiac, and adipose tissue development,” Molecular Cell, vol. 4, no. 4, pp. 585–595, 1999. View at Publisher · View at Google Scholar
  13. C. Schmidt, F. Bladt, S. Goedecke et al., “Scatter factor/hepatocyte growth factor is essential for liver development,” Nature, vol. 373, no. 6516, pp. 699–702, 1995. View at Publisher · View at Google Scholar
  14. Y. Uehara, O. Minowa, C. Mori et al., “Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor,” Nature, vol. 373, no. 6516, pp. 702–705, 1995. View at Publisher · View at Google Scholar
  15. D. W. Threadgill, A. A. Dlugosz, L. A. Hansen et al., “Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype,” Science, vol. 269, no. 5221, pp. 230–234, 1995. View at Publisher · View at Google Scholar
  16. M. Sibilia and E. F. Wagner, “Strain-dependent epithelial defects in mice lacking the EGF receptor,” Science, vol. 269, no. 5221, pp. 234–238, 1995. View at Publisher · View at Google Scholar
  17. C. B. Ware, M. C. Horowitz, B. R. Renshaw et al., “Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death,” Development, vol. 121, no. 5, pp. 1283–1299, 1995. View at Google Scholar
  18. R. Ohlsson, P. Falck, M. Hellström et al., “PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta,” Developmental Biology, vol. 212, no. 1, pp. 124–136, 1999. View at Publisher · View at Google Scholar
  19. S. J. Monkley, S. J. Delaney, D. J. Pennisi, J. H. Christiansen, and B. J. Wainwright, “Targeted disruption of the Wnt2 gene results in placentation defects,” Development, vol. 122, no. 11, pp. 3343–3353, 1996. View at Google Scholar
  20. T.-O. Ishikawa, Y. Tamai, A. M. Zorn et al., “Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis,” Development, vol. 128, no. 1, pp. 25–33, 2001. View at Google Scholar
  21. S. Tanaka, T. Kunath, A.-K. Hadjantonakis, A. Nagy, and J. Rossant, “Promotion to trophoblast stem cell proliferation by FGF4,” Science, vol. 282, no. 5396, pp. 2072–2075, 1998. View at Publisher · View at Google Scholar
  22. A. Erlebacher, K. A. Price, and L. H. Glimcher, “Maintenance of mouse trophoblast stem cell proliferation by TGF-β/activin,” Developmental Biology, vol. 275, no. 1, pp. 158–169, 2004. View at Publisher · View at Google Scholar
  23. J. Yan, S. Tanaka, M. Oda, T. Makino, J. Ohgane, and K. Shiota, “Retinoic acid promotes differentiation of trophoblast stem cells to a giant cell fate,” Developmental Biology, vol. 235, no. 2, pp. 422–432, 2001. View at Publisher · View at Google Scholar
  24. A. Nagy, E. Gocza, E. Merentes Diaz et al., “Embryonic stem cells alone are able to support fetal development in the mouse,” Development, vol. 110, no. 3, pp. 815–821, 1990. View at Google Scholar
  25. S. Z. Duan, C. Y. Ivashchenko, S. E. Whitesall et al., “Hypotension, lipodystrophy, and insulin resistance in generalized PPAR?-deficient mice rescued from embryonic lethality,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 812–822, 2007. View at Publisher · View at Google Scholar
  26. S. Kim and Y. Barak, unpublished dat.
  27. D. P. Hewitt, P. J. Mark, and B. J. Waddell, “Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure,” Biology of Reproduction, vol. 74, no. 1, pp. 23–28, 2006. View at Publisher · View at Google Scholar
  28. W. T. Schaiff, F. F. Knapp Jr., Y. Barak, T. Biron-Shental, D. M. Nelson, and Y. Sadovsky, “Ligand-activated PPARγ alters placental morphology and placental fatty acid uptake in mice,” Endocrinology, vol. 148, no. 8, pp. 3625–3634, 2007. View at Publisher · View at Google Scholar
  29. R. Asami-Miyagishi, S. Iseki, M. Usui, K. Uchida, H. Kubo, and I. Morita, “Expression and function of PPARγ in rat placental development,” Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 497–501, 2004. View at Publisher · View at Google Scholar
  30. D. B. Klinkner, H. J. Lim, E. Y. Strawn Jr., K. T. Oldham, and T. L. Sander, “An in vivo murine model of rosiglitazone use in pregnancy,” Fertility and Sterility, vol. 86, no. 4, supplement 1, pp. 1074–1079, 2006. View at Publisher · View at Google Scholar
  31. F. Yaris, E. Yaris, M. Kadioglu, C. Ulku, M. Kesim, and N. I. Kalyoncu, “Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman,” Reproductive Toxicology, vol. 18, no. 4, pp. 619–621, 2004. View at Publisher · View at Google Scholar
  32. N. I. Kalyoncu, F. Yaris, C. Ulku et al., “A case of rosiglitazone exposure in the second trimester of pregnancy,” Reproductive Toxicology, vol. 19, no. 4, pp. 563–564, 2005. View at Publisher · View at Google Scholar
  33. W. T. Schaiff, M. G. Carlson, S. D. Smith, R. Levy, D. M. Nelson, and Y. Sadovsky, “Peroxisome proliferator-activated receptor-γ modulates differentiation of human trophoblast in a ligand-specific manner,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 10, pp. 3874–3881, 2000. View at Publisher · View at Google Scholar
  34. T. Shalom-Barak, J. M. Nicholas, Y. Wang et al., “Peroxisome proliferator-activated receptor ? controls Muc1 transcription in trophoblasts,” Molecular and Cellular Biology, vol. 24, no. 24, pp. 10661–10669, 2004. View at Publisher · View at Google Scholar
  35. X. Zhang, T. Shalom-Barak, W. T. Schaiff, Y. Sadovsky, and Y. Barak, MS in preparatio.
  36. W. T. Schaiff, I. Bildirici, M. Cheong, P. L. Chern, D. M. Nelson, and Y. Sadovsky, “Peroxisome proliferator-activated receptor-γ and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4267–4275, 2005. View at Publisher · View at Google Scholar
  37. U. Elchalal, R. G. Humphrey, S. D. Smith, C. Hu, Y. Sadovsky, and D. M. Nelson, “Troglitazone attenuates hypoxia-induced injury in cultured term human trophoblasts,” American Journal of Obstetrics and Gynecology, vol. 191, no. 6, pp. 2154–2159, 2004. View at Publisher · View at Google Scholar
  38. A. Tarrade, K. Schoonjans, J. Guibourdenche et al., “PPAR?/RXRa heterodimers are involved in human CGß synthesis and human trophoblast differentiation,” Endocrinology, vol. 142, no. 10, pp. 4504–4514, 2001. View at Publisher · View at Google Scholar
  39. L. Pavan, A. Tarrade, A. Hermouet et al., “Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPAR? in cell invasion process,” Carcinogenesis, vol. 24, no. 8, pp. 1325–1336, 2003. View at Publisher · View at Google Scholar
  40. T. Fournier, K. Handschuh, V. Tsatsaris, and D. Evain-Brion, “Involvement of PPARγ in human trophoblast invasion,” Placenta, vol. 28, supplement, pp. S76–S81, 2007. View at Publisher · View at Google Scholar
  41. N. Kubota, Y. Terauchi, H. Miki et al., “PPAR? mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance,” Molecular Cell, vol. 4, no. 4, pp. 597–609, 1999. View at Publisher · View at Google Scholar
  42. M. Hemberger and J. C. Cross, “Genes governing placental development,” Trends in Endocrinology and Metabolism, vol. 12, no. 4, pp. 162–168, 2001. View at Publisher · View at Google Scholar
  43. Y. Barak, D. Liao, W. He et al., “Effects of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar
  44. K. Nadra, S. I. Anghel, E. Joye et al., “Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor ß/d,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 3266–3281, 2006. View at Publisher · View at Google Scholar
  45. J. M. Peters, S. S. T. Lee, W. Li et al., “Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor ß(d),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
  46. A. Chawla, C.-H. Lee, Y. Barak et al., “PPARd is a very low-density lipoprotein sensor in macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1268–1273, 2003. View at Publisher · View at Google Scholar
  47. Y. Barak, unpublished dat.
  48. S. A. Kliewer, K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans, “Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors,” Nature, vol. 358, no. 6389, pp. 771–774, 1992. View at Publisher · View at Google Scholar
  49. V. Sapin, S. J. Ward, S. Bronner, P. Chambon, and P. Dollé, “Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse,” Developmental Dynamics, vol. 208, no. 2, pp. 199–210, 1997. View at Publisher · View at Google Scholar
  50. V. Sapin, P. Dollé, C. Hindelang, P. Kastner, and P. Chambon, “Defects of the chorioallantoic placenta in mouse RXRα null fetuses,” Developmental Biology, vol. 191, no. 1, pp. 29–41, 1997. View at Publisher · View at Google Scholar
  51. H. M. Sucov, E. Dyson, C. L. Gumeringer, J. Price, K. R. Chien, and R. M. Evans, “RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis,” Genes and Development, vol. 8, no. 9, pp. 1007–1018, 1994. View at Publisher · View at Google Scholar
  52. P. Kastner, J. M. Grondona, M. Mark et al., “Genetic analysis of RXRa developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis,” Cell, vol. 78, no. 6, pp. 987–1003, 1994. View at Publisher · View at Google Scholar
  53. O. Wendling, P. Chambon, and M. Mark, “Retinoid X receptors are essential for early mouse development Land placentogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 2, pp. 547–551, 1999. View at Publisher · View at Google Scholar
  54. C. M. Tran and H. M. Sucov, “The RXRα gene functions in a non-cell-autonomous manner during mouse cardiac morphogenesis,” Development, vol. 125, no. 10, pp. 1951–1956, 1998. View at Google Scholar
  55. T. H.-P. Chen, T.-C. Chang, J.-O. Kang et al., “Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic factor,” Developmental Biology, vol. 250, no. 1, pp. 198–207, 2002. View at Publisher · View at Google Scholar
  56. Y. Zhu, C. Qi, Y. Jia, J. S. Nye, M. S. Rao, and J. K. Reddy, “Deletion of PBP/PARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality,” Journal of Biological Chemistry, vol. 275, no. 20, pp. 14779–14782, 2000. View at Publisher · View at Google Scholar
  57. C. Landles, S. Chalk, J. H. Steel et al., “The thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic development,” Molecular Endocrinology, vol. 17, no. 12, pp. 2418–2435, 2003. View at Publisher · View at Google Scholar
  58. M. Ito, C.-X. Yuan, H. J. Okano, R. B. Darnell, and R. G. Roeder, “Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action,” Molecular Cell, vol. 5, no. 4, pp. 683–693, 2000. View at Publisher · View at Google Scholar
  59. S.-Q. Kuang, L. Liao, H. Zhang et al., “Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality,” Journal of Biological Chemistry, vol. 277, no. 47, pp. 45356–45360, 2002. View at Publisher · View at Google Scholar
  60. Y.-J. Zhu, S. E. Crawford, V. Stellmach et al., “Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1986–1990, 2003. View at Publisher · View at Google Scholar
  61. P. Antonson, G. U. Schuster, L. Wang et al., “Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction,” Molecular and Cellular Biology, vol. 23, no. 4, pp. 1260–1268, 2003. View at Publisher · View at Google Scholar
  62. T.-P. Yao, S. P. Oh, M. Fuchs et al., “Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300,” Cell, vol. 93, no. 3, pp. 361–372, 1998. View at Publisher · View at Google Scholar
  63. Y. Oike, N. Takakura, A. Hata et al., “Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis,” Blood, vol. 93, no. 9, pp. 2771–2779, 1999. View at Google Scholar
  64. A. L. Kung, V. I. Rebel, R. T. Bronson et al., “Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP,” Genes and Development, vol. 14, no. 3, pp. 272–277, 2000. View at Google Scholar
  65. M. J. García-García, J. T. Eggenschwiler, T. Caspary et al., “Analysis of mouse embryonic patterning and morphogenesis by forward genetics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 5913–5919, 2005. View at Publisher · View at Google Scholar
  66. H. Baribault, J. Price, K. Miyai, and R. G. Oshima, “Mid-gestational lethality in mice lacking keratin 8,” Genes and Development, vol. 7, no. 7 A, pp. 1191–1202, 1993. View at Publisher · View at Google Scholar
  67. D. Jaquemar, S. Kupriyanov, M. Wankell et al., “Keratin 8 protection of placental barrier function,” Journal of Cell Biology, vol. 161, no. 4, pp. 749–756, 2003. View at Publisher · View at Google Scholar
  68. M. Hesse, T. Franz, Y. Tamai, M. M. Taketo, and T. M. Magin, “Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality,” EMBO Journal, vol. 19, no. 19, pp. 5060–5070, 2000. View at Publisher · View at Google Scholar
  69. Y. Tamai, T.-O. Ishikawa, M. R. Bösl et al., “Cytokeratins 8 and 19 in the mouse placental development,” Journal of Cell Biology, vol. 151, no. 3, pp. 563–572, 2000. View at Publisher · View at Google Scholar
  70. B. L. Bader, H. Rayburn, D. Crowley, and R. O. Hynes, “Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins,” Cell, vol. 95, no. 4, pp. 507–519, 1998. View at Publisher · View at Google Scholar
  71. J. Zhu, K. Motejlek, D. Wang, K. Zang, A. Schmidt, and L. F. Reichardt, “β8 Integrins are required for vascular morphogenesis in mouse embryos,” Development, vol. 129, no. 12, pp. 2891–2903, 2002. View at Google Scholar